🇺🇸 FDA
Patent

US 11291728

Anhydrous sodium thiosulfate and formulations thereof

granted A61KA61K33/04A61K33/243

Quick answer

US patent 11291728 (Anhydrous sodium thiosulfate and formulations thereof) held by Fennec Pharmaceuticals, Inc. expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Fennec Pharmaceuticals, Inc.
Grant date
Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K33/04, A61K33/243, A61K47/02, A61K47/18